Estradiol Acetate Patent Expiration
Estradiol Acetate is Used for treating vasomotor symptoms associated with menopause. It was first introduced by Millicent Holdings Ltd
Estradiol Acetate Patents
Given below is the list of patents protecting Estradiol Acetate, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Femring | US5855906 | Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors |
Dec 19, 2015
(Expired) | Millicent |
Femtrace | US6962908 | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Dec 21, 2021
(Expired) | Apil |
Femtrace | US7572779 | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation | Oct 02, 2025 | Apil |
Femtrace | US7799771 | Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
Dec 21, 2021
(Expired) | Apil |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳